[su_dropcap style="flat" size="3" class=""]T[/su_dropcap]imes are tough for pharma marketing and they will get tougher. Increasingly, industry executives are of the view that pharma’s age old marketing models are no longer returning predictable outcomes as they did in the past.
In the past, marketing teams worked to create eye-grabbing communication while sales teams sweated it out to attract customers to the top of the physician funnel. For ages, pharma marketers excelled at managing systems that ensured messaging consistency and in-clinic foot-falls.
The take-home message is that pharma marketers are going to fail if they continue to make decisions based on intuition that was acquired a decade back. A clear need of the hour is to go back to the drawing board and redesign business models so that they give us a unique advantage to sustain growth in the future when these disruptions reach maturity.
Free Membership Required
You must be a Free member to access this content.
